Scabies
📧 Sign up to get email alerts when something new happens for Scabies.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-07-09FDA Approved: IVERMECTIN — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Actavis Pharma’s ivermectin, confirming approval of its generic antiparasitic product.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Azithromycin - Ivermectin Mass Drug Administration for Skin Disease [Phase 4]
Phase 4 trial update evaluating azithromycin-ivermectin mass drug administration for skin diseases, including scabies and yaws, with results…
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands [Phase 3]
A Phase 3 clinical trial completed in the Solomon Islands evaluating how community treatment for scabies affects head lice prevalence.
-
FDA approval · 2019-04-03FDA Approved: PERMETHRIN — Original Application (Encube Ethicals, Inc.)
FDA approved Permethrin Cream 5% W/W as an original generic (ANDA) for Encube Ethicals, Inc.
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies [Phase 3]
Phase 3 trial assessing therapeutic equivalence of Permethrin Cream 5% for treating scabies has completed; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs ) [Phase 3]
A Phase 3 clinical trial evaluating the safety of co-administration of IDA and azithromycin for neglected tropical diseases (trachoma and ya…
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies [Phase 3]
Phase 3 trial completed evaluating Natroba for safety and efficacy in treating scabies; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies [Phase 3]
Phase 3 trial completed evaluating the safety and efficacy of Natroba for the treatment of scabies.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: PCR (Polymerase Chain Reaction) Assay for Diagnosis of Sarcoptes Scabiei
This update reports results from a clinical trial evaluating a PCR assay for diagnosing scabies caused by Sarcoptes scabiei.
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies [Phase 3]
This Phase 3 study compared generic permethrin cream 5% to Elimite for treatment of scabies and has completed. It reports therapeutic equiva…
-
FDA approval · 2016-02-12FDA Approved: ELIMITE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for ELIMITE (permethrin) submitted by Aurobindo Pharma Limited.
-
FDA approval · 2014-03-10FDA Approved: CROTAN — Supplemental Application (Marnel Pharmaceuticals, Inc.)
FDA approved a supplemental application for CROTAN (crotamiton) from Marnel Pharmaceuticals, Inc. under an ANDA.
-
FDA approval · 2013-10-30FDA Approved: EURAX — Supplemental Application (Journey Medical Corporation)
The FDA approved a supplemental application for EURAX (crotamiton) submitted by Journey Medical Corporation.
-
CLINICAL_TRIALS research · 2009-04-21Clinical Trial Update: Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory
A completed clinical trial evaluating a regional healthy skin program in remote Aboriginal communities of Australia's Northern Territory to …
-
CLINICAL_TRIALS trial_result · 2008-05-02Clinical Trial Update: Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji
An NIAID-sponsored clinical trial in Fiji evaluated the prevalence of Group A Streptococcal pyoderma (impetigo) and scabies in infants. The …
-
FDA approval · 2008-02-26FDA Approved: STROMECTOL — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for Stromectol (ivermectin) filed by Merck Sharp & Dohme LLC, granting changes to the drug's labelin…
-
CLINICAL_TRIALS research · 2008-01-25Clinical Trial Update: Prevalence of RHD, Pyoderma and Scabies in Children in Fiji
A completed clinical trial update assessing the prevalence of rheumatic heart disease, pyoderma, and scabies among children in Fiji.
-
CLINICAL_TRIALS trial_result · 2007-12-28Clinical Trial Update: Comparison of the Efficacy and Safety of Ivermectin to Permethrin [Phase 2]
Phase 2 trial evaluating the efficacy and safety of ivermectin compared with permethrin for treating scabies.